{"title":"Chiral separation of sitagliptin phosphate enantiomer by HPLC using amylose based chiral stationary phase","authors":"Bhimireddy Venkata Rami Reddy , Nanduri Raman , Badam Sai Kumar , Chintala Rambabu","doi":"10.1016/j.jopr.2013.06.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Although a number of methods are available for evaluating sitagliptin phosphate (SGP), a common method for separation if its potential enantiomer and its possible impurities with good efficiency remains unavailable. With the objective of developing a method for rapid separation with shorter runtimes, a simple, precise, accurate stability indicating normal phase High-performance liquid chromatographic (NRP-HPLC) coupled with a photodiode array detector method was developed for the quantitative determination of (S)-enantiomer in API substance and as well as drug product.</p></div><div><h3>Methods</h3><p>The proposed novel method uses the mixture of n-heptane-ethanol-diethylamine (DEA) 35:65:0.1 (v/v/v) as a mobile phase. The enantiomer of sitagliptin phosphate was baseline resolved on a Chiralpak AD-H (250 mm×4.6 mm, 5 μm) column. The flow rate of the mobile phase is 1.0 mL/min and the detector wavelength monitored at 265 nm. The developed method was extensively validated.</p></div><div><h3>Result</h3><p>In these conditions, linearity over the concentration range 400-2250 ng/ml for (S)- enantiomer was obtained. The limit of detection and quantification were 150 and 400 ng/ml, respectively. The intra and inter-day precision was less than 1.5%. The recovery of (S)- enantiomer was within 107% in bulk drug.</p></div><div><h3>Conclusion</h3><p>The proposed method was found to be suitable, precise, and accurate for the quantitative determination of (S)-enantiomer in bulk drugs as well as in pharmaceutical formulations.</p></div>","PeriodicalId":16787,"journal":{"name":"Journal of Pharmacy Research","volume":"7 6","pages":"Pages 546-550"},"PeriodicalIF":0.0000,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jopr.2013.06.014","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0974694313002569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
Background
Although a number of methods are available for evaluating sitagliptin phosphate (SGP), a common method for separation if its potential enantiomer and its possible impurities with good efficiency remains unavailable. With the objective of developing a method for rapid separation with shorter runtimes, a simple, precise, accurate stability indicating normal phase High-performance liquid chromatographic (NRP-HPLC) coupled with a photodiode array detector method was developed for the quantitative determination of (S)-enantiomer in API substance and as well as drug product.
Methods
The proposed novel method uses the mixture of n-heptane-ethanol-diethylamine (DEA) 35:65:0.1 (v/v/v) as a mobile phase. The enantiomer of sitagliptin phosphate was baseline resolved on a Chiralpak AD-H (250 mm×4.6 mm, 5 μm) column. The flow rate of the mobile phase is 1.0 mL/min and the detector wavelength monitored at 265 nm. The developed method was extensively validated.
Result
In these conditions, linearity over the concentration range 400-2250 ng/ml for (S)- enantiomer was obtained. The limit of detection and quantification were 150 and 400 ng/ml, respectively. The intra and inter-day precision was less than 1.5%. The recovery of (S)- enantiomer was within 107% in bulk drug.
Conclusion
The proposed method was found to be suitable, precise, and accurate for the quantitative determination of (S)-enantiomer in bulk drugs as well as in pharmaceutical formulations.